Compare PALI & RNTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PALI | RNTZ |
|---|---|---|
| Founded | 1996 | 2013 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 249.2M | 271.0M |
| IPO Year | 2019 | 2023 |
| Metric | PALI | RNTZ |
|---|---|---|
| Price | $1.16 | $4.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $9.80 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 12.9K |
| Earning Date | 11-09-2026 | 11-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $260,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $1.17 | $4.00 |
| 52 Week High | $2.86 | $5.18 |
| Indicator | PALI | RNTZ |
|---|---|---|
| Relative Strength Index (RSI) | 29.91 | 29.15 |
| Support Level | N/A | $4.00 |
| Resistance Level | $2.19 | $5.18 |
| Average True Range (ATR) | 0.11 | 0.46 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 2.06 | 22.46 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.